Pasar al contenido principal

MODELOS PRECLINICOS PERSONALIZADOS PARA NEOPLASIAS MALIGNAS RARAS DE LINFOCITOS T HUMANOS: UNA NECESIDAD PARA LA TERAPIA DIRIGIDA

PID2021-125501OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nonsense CD247 mutations show dominant-negative features in T-cell receptor expression and function

  • Briones, Alejandro C
  • Megino, Rebeca F
  • Marin, Ana V
  • Chacón-Arguedas, Daniel
  • García-Martinez, Elena
  • Balastegui-Martín, Héctor
  • Reyburn, Hugh T
  • Henrickson, Sarah E
  • Rodríguez-Sainz, Carmen
  • Seoane-Reula, Elena
  • Sanchez-Mateos, Paloma
  • Cardenas, Paula P
  • Regueiro, Jose R
The invariant TCR ζ/CD247 homodimer is crucial for TCR/CD3 expression and signaling through its 3 immunoreceptor tyrosine-based activation motifs (ITAMs). Homozygous null mutations in CD247 lead to immunodeficiency, while carriers exhibit 50% reduced surface CD3. It is unclear whether carriers of other CD247 variants show dominant-negative effects., This work was supported by grants from the Ministerio de Economía y Competitividad (MINECO PID2021-125501OB-I00 and RTI2018-095673-B-I00) and Asociación Española Contra el Cancer (AECC PROYE20084REGU). A.C.B. was supported by Complutense University scholarship (CT27/16 and CT31/21). R.F.M. and D.C.A. were supported by the Spanish Ministry of Science, Innovation and Universities (FPU19/03136 and PRE2019-088150). P.P.C. was supported by Juan de la Cierva-Incorporacion fellowship (IJCI-2014-19262)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discordant Restoration of TCR Expression and Function by CD247 Somatic Reversions

  • Briones, Alejandro C.
  • Marin, Ana V.
  • Chaparro-García, Rebeca
  • López-Nevado, Marta
  • Abia, David
  • Estevez-Benito, Ivan
  • Chacón-Arguedas, Daniel
  • Fernández-Malavé, Edgar
  • Cardenas, Paula P.
  • Regueiro, José R.
Background: The CD247 chain of the T-cell receptor (TCR) is essential for normal T cell development and function. Reported CD247-deficient patients showed severe immunodeficiency despite the presence of two populations of peripheral T cells, most with low TCR levels carrying the germline variant and a few with higher TCR levels due to somatic reversion. However, the revertant T cells remained a minority and did not improve the patients’ clinical status. Purpose: To compare the capability of somatic revertant variants of CD247 germline changes (p.M1T and p.Q70X) to restore TCR expression and function. Methods: CD247 wild-type (WT) and p.Q70L/W/Y somatic variants were individually introduced in CD247-deficient mouse (MA5.8), human mutant (PM1T), and CRISPR/Cas9-generated Jurkat (ZKO) T cell lines by nucleofection or transduction. Results: MA5.8 mouse T cells do not accurately model human CD247 deficiencies, as Q70X restores TCR expression in MA5.8 but not in human cells. In human cell models, all somatic revertant variants restored TCR expression with varying degrees (WT = Q70L > Q70W > Q70Y). In contrast, TCR-induced activation events, such as CD69/CD25 upregulation, showed a different hierarchy (WT = Q70W > Q70L = Q70Y). Furthermore, all CD247 somatic variants failed to induce TCR-mediated ZAP70 tyrosine phosphorylation compared to WT. Conclusion: Somatic reversions, such as those detected in patients with pathogenic CD247 germinal changes, display a discordant capability to rescue TCR expression versus function. These findings shed light on the role of CD247 in TCR expression and function during human T cell development, with implications for immunodeficiencies, as well as for the biological consequences of CD247 somatic mosaicism., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This study was supported by grants from the Ministerio de Economía y Competitividad (MINECO RED2022-134750-T, PID2021-125501OB-I00, and PID2024-155827OB-I00), the Comunidad Autónoma de Madrid (P2022/BMD-7278, PR38/21–13 ANTICIPA-CM and CAM B2017/BMD3673), and the Asociación Española Contra el Cáncer (AECC PROYE20084REGU). A.C.B. was supported by Complutense University scholarship Q16 (CT27/16 and CT31/21). P.P.C. was supported by the MINECO Juan de la Cierva—Incorporación fellowship (IJCI-2014–19262).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Post-COVID syndrome patients show reduced anti-Spike antibodies compared to COVID-recovered controls, but enhanced IgG4/IgG1 switch after the third vaccine dose

  • Rossi, Nineth
  • Benítez-Cruz, Javier
  • Marín-García, Patricia
  • Azcárate, Isabel G.
  • González-Escalada, Alba
  • Hervás, Oscar G.
  • Alarcón, Balbino
  • Regueiro, José R.
  • Bautista, José M.
  • Martinez-Quiles, Narcisa
Introduction: Long COVID and post-COVID syndromes represent a significant global health crisis and a substantial societal challenge. Although an altered immunological response has been suggested as a possible underlying mechanism, the antibody response to vaccination and infection of the patients remains unclear. Methods: We studied a post-COVID syndrome cohort compared to a COVID-recovered cohort. Initially, we established the risk factors and the evolution of symptoms. Then, we analyzed the antibody response, focusing on immunoglobulin subclasses. Apart from determining immunoglobulin G (IgG) against the Nucleocapsid, which is a marker of infection, we analyzed IgG and its subclasses against the full-length Spike, and against the receptor-binding domain (RBD). Additionally, we examined the switch to IgG4, which can be promoted by repeated antigen exposure. Results: We show the major risk factors for developing post-COVID syndrome, such as infection before vaccination and comorbidities. Furthermore, we describe the evolution of the post-COVID symptoms, which agrees with previous reports. Regarding the antibody response, we found that compared to COVID-recovered individuals, post-COVID patients present readily detectable anti-Nucleocapsid IgG but low quantities of anti-Spike antibodies. Nevertheless, the anti-RBD IgG1 levels are similar between post-COVID and COVID samples. Interestingly, post-COVID patients with three vaccine doses, who were infected before vaccination by the Wuhan strain and subsequently reinfected post-Omicron, show decreased Spike response but intensified anti-RBD IgG4/IgG1 switch, compared to their non-reinfected post-COVID counterparts. Discussion: Our results support a differential antibody response in post-COVID versus COVID-recovered patients, which might be relevant for post-COVID syndrome treatment, including appropriate recall vaccination strategies for the still-circulating SARS-CoV-2., The author(s) declare financial support was received for the research and/or publication of this article. Research supported by the European Social Funds REACT-UE through the “Prevention of COVID-19 in the Madrid Region (ANTICIPA-CM REACT-UCM) project (2021–2023), coordinated by JB with JR and JB as subproject IPs. Supported in part by Ministerio de Ciencia, Innovación y Universidades (MICIU) grant PID2021-125501OB-I00 and PID2024-155827OB-I00, and Comunidad de Madrid network on complement-III Ref. P2022/BMD-7278 to JR. JB-C was under contract UCM personnel (NM-Q, Ref. CT58/23-INVM-21) by the Program Investigo from the Spanish Ministry of Labor. European plan for Recovery, Transformation and Resilience.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Discordant Restoration of TCR Expression and Function by CD247 Somatic Reversions

  • Briones Contreras, Alejandro
  • Marín Marín, Ana Victoria
  • Chaparro García, Rebeca
  • López Nevado, Marta
  • Abia, David
  • Estevez Benito, Ivan
  • Chacón Arguedas, Carlos Daniel
  • Fernández Malavé, Edgar Gonzalo
  • Cárdenas Mastrascusa, Paula Patricia
  • Regueiro González-Barros, José Ramón
Background The CD247 chain of the T-cell receptor (TCR) is essential for normal T cell development and function. Reported CD247-deficient patients showed severe immunodeficiency despite the presence of two populations of peripheral T cells, most with low TCR levels carrying the germline variant and a few with higher TCR levels due to somatic reversion. However, the revertant T cells remained a minority and did not improve the patients’ clinical status. Purpose To compare the capability of somatic revertant variants of CD247 germline changes (p.M1T and p.Q70X) to restore TCR expression and function. Methods CD247 wild-type (WT) and p.Q70L/W/Y somatic variants were individually introduced in CD247-deficient mouse (MA5.8), human mutant (PM1T), and CRISPR/Cas9-generated Jurkat (ZKO) T cell lines by nucleofection or transduction. Results MA5.8 mouse T cells do not accurately model human CD247 deficiencies, as Q70X restores TCR expression in MA5.8 but not in human cells. In human cell models, all somatic revertant variants restored TCR expression with varying degrees (WT = Q70L > Q70W > Q70Y). In contrast, TCR-induced activation events, such as CD69/CD25 upregulation, showed a different hierarchy (WT = Q70W > Q70L = Q70Y). Furthermore, all CD247 somatic variants failed to induce TCR-mediated ZAP70 tyrosine phosphorylation compared to WT. Conclusion Somatic reversions, such as those detected in patients with pathogenic CD247 germinal changes, display a discordant capability to rescue TCR expression versus function. These findings shed light on the role of CD247 in TCR expression and function during human T cell development, with implications for immunodeficiencies, as well as for the biological consequences of CD247 somatic mosaicism.